Jiangsu Vanguard Pharmaceutical Co.,Ltd

Indications:

1. Treatment of Microangiopathies:

Diabetic microangiopathies (retinopathy and glomerulosclerosis [Kimmelstiel-Wilson syndrome]).

Microvascular injuries associated with increased capillary fragility and permeability, capillary bleeding, and acrocyanosis.

2.Adjunctive Therapy for Chronic Venous Insufficiency (CVI):

Varicose vein syndromes and sequelae (post-thrombotic syndrome, leg ulcers, stasis dermatitis, peripheral edema, etc.).

Administration:

Diabetic Retinopathy: 1 capsule at a time, 3 times a day (morning, noon, evening).
Other Indications: 1 capsule at a a time, 2 times a day (morning and evening). If clinical improvement occurs, omit the evening dose after approximately 1 month.

Specifications:

0.5g × 36 capsules